Showing 941-950 of 987 results for "".
- Valeant Pharmaceuticals Announces Appointment of Dr. Ari Kellen to Executive Management Teamhttps://practicaldermatology.com/news/20131125-valeant_pharmaceuticals_announces_appointment_of_dr_ari_kellen_to_executive_management_team/2459405/Valeant Pharmaceuticals International, Inc. announced that Dr. Ari Kellen has been named to Valeant's Executive Management Team and will assume the role of Executive Vice President/Company Group Chairman, effective January 1, 2014. Dr. Ari Kellen was a senior partner in McKinsey & Company's Mid-At…
- Caliber Imaging & Diagnostics Appoints Robert P. Fischmann VP of Operationshttps://practicaldermatology.com/news/20131125-caliber_imaging__diagnostics_appoints_robert_p_fischmann_vp_of_operations/2459406/Caliber Imaging & Diagnostics, formerly Lucid, Inc., has appointed Robert P. Fischmann to the role of Vice President of Operations, a newly created position. Mr. Fischmann's responsibilities at Caliber I.D. will include managing all of the Company's production control, production process developme…
- Lithera Announces Appointment of Dr. Lincoln Krochmal as Chief Medical Officerhttps://practicaldermatology.com/news/20131121-lithera_announces_appointment_of_dr_lincoln_krochmal_as_chief_medical_officer/2459407/Lincoln Krochmal, MD was recently appointed as Chief Medical Officer of Lithera, Inc. According to the company, this appointment reflects the company's continued growth as it prepares to enter late-stage clinical trials and to commercialize its lead product candidate, LIPO-202 (Salmeterol Xinafoate…
- Actelion Launches Valchlor to Treat Stage IA and IB Mycosis Fungoides-type Cutaneous T-cell Lymphomahttps://practicaldermatology.com/news/20131119-actelion_launches_valchlor_to_treat_stage_ia_and_ib_mycosis_fungoides-type_cutaneous_t-cell_lymphoma/2459409/The FDA approved Actelion's Valchlor (mechlorethamine), the first and only FDA-approved topical formulation of mechlorethamine. Valchlor, a gel that is applied topically once a day, is an alkylating drug indicated to treat patients with stage IA and IB mycosis fungoides-type cutaneous T-cell lympho…
- Cosmetic Surgery Forum Announces Innovators in Dermatology Recipientshttps://practicaldermatology.com/news/20131107-cosmetic_surgery_forum_announces_innovators_in_dermatology_recipients/2459420/The upcoming Cosmetic Surgery Forum (www.cosmeticsurgeryforum.com), taking place at the ARIA Resort and Casino in Las Vegas from December 5-7, recently announced the recipients of its “Innovators in Dermatology” presentation. Among those honored this year will be Jim Hartman, Vice President of US A…
- Subliminally Exposed to be Presented at Cosmetic Surgery Forumhttps://practicaldermatology.com/news/20131029-subliminally_exposed_to_be_presented_at_cosmetic_surgery_forum/2459426/Based on the New York Times and USA Today best seller, Subliminally Exposed, Dr. Steven Dayan and Valerie Monroe will present at this year's Cosmetic Surgery Forum. The 75-minute presentation, which is free for registered attendees, will expose the why behind people's “motives and actions in dating…
- New Stelara Data Show Inhibition Of Joint Destruction In Psoriatic Arthritis Patientshttps://practicaldermatology.com/news/20131029-new_stelara_data_show_inhibition_of_joint_destruction_in_psoriatic_arthritis_patients/2459427/New findings from two integrated Phase III Janssen Research & Development, LLC (Janssen)-sponsored studies showed treatment with ustekinumab (Stelara) resulted in significantly greater inhibition of structural damage in patients with active psoriatic arthritis compared with placebo. Pre-specified …
- Restoration Robotics Announces the Launch Of ARTAS Hair Studio™https://practicaldermatology.com/news/20131025-restoration_robotics_announces_the_launch_of_artas_hair_studio/2459428/At this year's International Society of Hair Restoration Surgery (ISHRS) conference in San Francisco (October 23-27), Restoration Robotics will introduce the ARTAS Hair Studio™, a new product that expands the clinical indication and capability of their revolutionary ARTAS® Robotic System. The ARTA…
- Robert Ryan of Scioderm Appointed Member of DebRA Boardhttps://practicaldermatology.com/news/20131021-robert_ryan_of_scioderm_appointed_member_of_debra_board/2459434/Scioderm, Inc.'s co-founder and CEO Robert Ryan, PhD was appointed to the board of directors of the Dystrophic Epidermolysis Bullosa Research Association of America (DebRA). DebRA is the only national non-profit group dedicated to funding research and providing services and programs for those with …
- ASDS Elects New Officers, Board Membershttps://practicaldermatology.com/news/20131016-asds_elects_new_officers_board_members/2459435/The American Society for Dermatologic Surgery (ASDS) announces the election of Naomi Lawrence, M.D., as Vice President as well as a new Secretary and three new board members during its Annual Meeting in Chicago. The Society's newly elected officials will join President Mitchel P. Goldman, M.D., and…